VRTX : Analysis & Opinions

  1. Vertex Posts 3Q Loss of $42 Million (VRTX)

    October 26, 2016
    The results fell below the projected profit of 19 cents that analysts had estimated.
  2. Vertex Begins Two Cystic Fibrosis Studies (VRTX)

    October 26, 2016
    Vertex Pharmaceuticals launched two Phase 2 studies to test a new class of cystic fibrosis drugs.
  3. Downside Ahead For Biotech Stocks?

    June 10, 2016
    Since the August 24 and January 20 lows in the stock market, Biotechnology stocks have been massive under-performers. Currently ...
  4. 5 Punished Stocks: Are They Bargains? (ENDP,VRTX)

    March 31, 2016
    These five stocks have been slammed recently. Does this mean they are now bargains?
  5. The Top 3 Biotechnology Stocks for 2016 (AMGN, VRX)

    December 30, 2015
    Find out more about the top three biotechnology stocks to consider in 2016, and learn about their characteristics and why ...
  6. Biogen And Gilead Sciences Catch The Eye Of Short Sellers

    August 27, 2015
    Between the July 31 and August 14 settlement dates, the number of shares short in the leading biotech and emerging pharmaceutical ...
  7. Strategies For Playing The Confirmation Trade

    July 7, 2015
    Trends often escalate when the confirmation process is completed after a breakout or breakdown.
  8. Vertex Approaches Its Make-or-Break Day (VRTX, AAPL)

    June 30, 2015
    Vertex Pharmaceuticals (NASDAQ: VRTX) is circling in a holding pattern. But touchdown is going to be so spectacular that ...
  9. Vertex Double Downs on Cystic Fibrosis (VRTX)

    June 10, 2015
    Source: Vertex Pharmaceuticals. Vertex Pharmaceuticals (NASDAQ: VRTX) already has a cystic fibrosis drug, Kalydeco, on the ...
  10. The FDA Committee Vote That Could Sink Vertex (VRTX)

    May 28, 2015
    The headlines after this month's FDA advisory committee meeting reviewing Vertex Pharmaceuticals' (NASDAQ: VRTX) cystic ...
  11. 3 Biotech Stocks With Rising Short Interest

    April 28, 2015
    While short interest in most of the leading biotechs and emerging pharmaceuticals shrank between the March 31 and April ...
  12. Vertex Earnings Preview: What You Should Know (VRTX)

    April 24, 2015
    When it comes to dramatically improving patients' quality of life, Vertex Pharmaceuticals (NASDAQ: VRTX) has been making ...
  13. Is the FDA Worried About Vertex's New Drug? (VRTX)

    March 31, 2015
    Vertex Pharmaceuticals' (NASDAQ: VRTX) first cystic fibrosis drug, Kalydeco, was approved nearly three months before the ...
  14. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  15. Biotechnology Stocks To Keep on the Radar

    April 23, 2014
    Health care is showing a resurgance, lead by biotechnology. Here are the opportunites to watch.
Trading Center